Resideo Technologies has just reported Q1 2026 results — and the market's initial verdict has been blunt. The stock fell 2.1% on Tuesday and is down 9.1% on the week to $36.68, a jarring move for a building-products name reaffirming its full-year outlook. The real standout this week, however, is not the price drop. It is the options market, which is flashing the most defensive signal in a year.
The options story dominates the positioning picture. The put/call ratio jumped to 0.91 on May 12 — the highest reading in 52 weeks and more than four standard deviations above the 20-day mean of 0.40. That is an extraordinary skew. At nearly double the recent average, the options market shifted sharply toward downside protection in a single session. The timing is hard to separate from the earnings release: Resideo delivered Q1 results after the close on May 12, and options traders appear to have loaded up on puts ahead of or in reaction to that print. By contrast, short interest tells a more moderate story. At 3.3% of the free float, it is not a crowded short — but it has built steadily. SI is up 14% on the week and 27% over the past month, accelerating from roughly 3.6 million shares in early April to 4.9 million now. Borrow conditions remain loose. The cost to borrow is just 0.49%, barely changed over the month, and availability remains ample. There is no squeeze pressure here — this is a deliberate, measured accumulation of short positions rather than a panic pile-on.
The Street view adds a further wrinkle. Analyst coverage has been broadly constructive for much of the past year, with Morgan Stanley upgrading to Overweight last August and lifting its target to $50 in February 2026. Oppenheimer also raised its target to $48. But most of the meaningful activity is from February 2026 or earlier — 77 days ago — and the stock has moved materially since those targets were set. At $36.68, REZI is trading at a 25% discount to the consensus mean target of $49. That gap is real, but it does not automatically make the stock cheap; it may reflect a Street that has not yet re-marked its models post-earnings. JP Morgan sits on the sidelines at Neutral, a residual from its April 2025 downgrade. Factor scores offer a nuanced read: the EPS surprise rank is strong at the 86th percentile, suggesting the company has consistently beaten estimates, while the ORTEX short score of 37.5 sits in the middle of the range — not particularly alarming, but up about two points on the week.
The Q1 print itself and the company's guidance are central to understanding the week. Resideo reaffirmed its full-year 2026 outlook and guided Q2 revenue of $1.92 billion to $1.94 billion, with EPS of $0.71 to $0.75. The ADI Global Distribution spinoff — a key strategic catalyst the bull case has long relied on — is now targeted for mid-Q3 to mid-Q4. That timeline is firm enough to anchor expectations, but the market reaction suggests investors wanted something more. The valuation sits at roughly 8.2x EV/EBITDA and 11.4x trailing earnings — modest multiples for an industrial, but both have expanded 30 days prior to this week's print, meaning the re-rating was already baked in before the drop. The stock now gives some of that premium back.
Closest peers closed broadly in the red alongside REZI. AMWD was the worst performer in the group, off 12% on the week, while GFF dropped 8.5% and HAYW fell 4.4%. Building-products names are under uniform pressure, which provides at least partial cover for the Resideo selloff — this is not a purely idiosyncratic move. TREX, a notable exception, managed a 3.9% weekly gain, suggesting the market is discriminating within the group.
The next scheduled earnings event is June 3 — meaning the market will not have to wait long for the next data point. In the meantime, the question is whether the options skew fades quickly now that earnings are out, or whether traders see the ADI spin timeline and post-print guidance as reasons to hold protective positioning a while longer.
See the live data behind this article on ORTEX.
Open REZI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
